Silexion Therapeutics Reports Preclinical Data for SIL-204 in Combination with 1L Chemotherapies for Pancreatic Cancer
Shots: Silexion reported preclinical data of SIL-204 (siRNA agent) + 5-fluorouraci...
Light Horse Therapeutics Partners with Novartis to Discover Therapies for Cancer Treatment
Shots: Light Horse has entered into a multi-target partnership with Novartis to di...
Atavistik Bio Partners with Pfizer to Discover Novel Precision Allosteric Therapeutics
Shots: Atavistik Bio has signed a research collaboration with Pfizer to discover n...
Axcelead DDP Collaborates with Astellas to Discover Candidates for Targeted Protein Degraders
Shots: Axcelead Drug Discovery Partners and Astellas have signed a drug discovery...
KIND Pharmaceutical Reports Preclinical Results of AND017 in Animal Models of Multiple Disorders
Shots: Kind highlighted the preclinical data of AND017 in Townes SCD, inducible Mu...
SELLAS Reports Data from Preclinical Studies Suggesting ASXL1 Mutations as Predictor of SLS009 Response in Solid Tumors
Shots: SELLAS tested SLS009 in 18 patient-derived cell lines (PDCs) at different c...
